GLP-1s and Cancer Risk: Study Sees Mixed Signals
Summary
A new study links GLP-1s to a lower risk of obesity-related cancers, but only compared with drugs often reserved for poorly controlled or advanced diabetes -- raising questions about confounding.
Description from Medscape.
Who is covering this
-
GLP-1s and Cancer Risk: Study Sees Mixed Signals
A new study links GLP-1s to a lower risk of obesity-related cancers, but only compared with drugs often reserved for poorly controlled or advanced diabetes -- raising questions about confounding.
Comments
Comments need JavaScript.